Tofacitinib De-escalation in UC: Proceed With Caution
Patients with ulcerative colitis who de-escalate tofacitinib therapy may experience a disease flare, and not all will recapture clinical response with dose re-escalation, real-world data show.
Medscape Medical News
source https://www.medscape.com/viewarticle/992245?src=rss
Medscape Medical News
source https://www.medscape.com/viewarticle/992245?src=rss
Comments
Post a Comment